TMS Therapy & Spravato Depression Treatment in Johns Creek, GA

Specialized Depression Treatment in Johns Creek

Advanced Psychiatric Care When Medications Haven’t Been Enough

Ready to explore TMS or Spravato in Johns Creek?

Call (770) 615-0226 or complete our interest form. Our team will verify your insurance and schedule your consultation — usually within 1–2 business days. Telehealth available. Saturday appointments offered.

Advanced Depression Treatment in Johns Creek, GA

When antidepressants haven’t brought lasting relief, many Johns Creek residents feel like they’re out of options, but that’s not true. At Empower Psychiatry & Sleep, we specialize in exactly the cases that are hardest to treat, offering two of the most advanced interventional psychiatric treatments available: BrainsWay Deep TMS therapy and Spravato (esketamine). Our Suwanee clinic is just minutes from Johns Creek, giving patients in the 30022, 30024, and 30097 zip codes convenient access to FDA-approved, drug-free alternatives that have transformed outcomes for people living with treatment-resistant depression, OCD, and severe anxiety. Led by board-certified psychiatrist Dr. Ravi Singareddy, affiliated with the Emory Healthcare Network, our team is here when standard treatments haven’t worked.

Finding the Right Psychiatrist in Johns Creek, GA

If you have been searching for a psychiatrist in Johns Creek, GA, you are likely past the point of wanting another general referral. Many of our Johns Creek patients come to us after months or years of medications that helped a little, or not at all. They want a clear diagnosis, a specialist who has seen cases like theirs, and a plan that goes further than trying the next prescription.

Our practice is led by Dr. Ravi Singareddy, a board-certified psychiatrist affiliated with the Emory Healthcare Network, alongside a team of board-certified psychiatric nurse practitioners. Every new patient starts with a full psychiatric evaluation, in person or by telehealth, so your treatment plan is built on your history rather than a template.

Depression Treatment in Johns Creek When Medications Haven’t Worked

Treatment-resistant depression is common, and it is not a personal failure. For Johns Creek depression treatment that goes beyond standard antidepressants, we offer two FDA-approved options under one roof: BrainsWay Deep TMS, which uses magnetic pulses to stimulate the areas of the brain involved in mood, and Spravato (esketamine), a nasal spray that works on a different brain pathway than traditional antidepressants. Some patients are candidates for one, some for the other, and some benefit from a combined approach.

Our Suwanee office is about 10 to 15 minutes from most Johns Creek neighborhoods, with weekday and Saturday morning appointments. Our team handles insurance verification and prior authorization, so you know your out-of-pocket cost before treatment begins, and no referral is needed. To schedule a consultation with a psychiatrist serving Johns Creek, GA, call (770) 615-0226 or complete our interest form.

Two Breakthrough Treatments — One Expert Team

FDA-cleared for depression & OCD. Non-invasive magnetic stimulation. No medication side effects. 20 min sessions. Drive yourself home. 36 sessions over 6–7 weeks. Covered by most insurances.

FDA-approved for treatment-resistant depression. Nasal spray administered in-office. Rapid relief often within hours to days. Covered by Medicare & most insurance. Dr. Singareddy is REMS-certified.

About TMS Therapy for Johns Creek Patients

TMS (Transcranial Magnetic Stimulation) uses precisely targeted magnetic pulses, similar to those used in MRI machines to stimulate relevant neural circuits in the brain. Over a course of treatment, this resets the brain’s mood-regulating pathways in a way that medications attempt to achieve chemically, but without the systemic side effects.

At Empower Psychiatry, we use the BrainsWay Deep TMS system, which uses a patented H-Coil helmet that reaches deeper and broader brain regions than standard TMS figure-8 coils. It is the most advanced TMS technology available and is FDA-cleared for Major Depressive Disorder, Anxious Depression and OCD, making it the right choice for Johns Creek patients dealing with either condition, or both.

TMS is ideal if you have tried antidepressants and found them ineffective or intolerable. There is no sedation, no weight gain, no sexual dysfunction, and no cognitive impairment. You sit in a comfortable chair, remain fully awake, and drive home immediately after each session.

About Spravato (Esketamine) for Johns Creek Patients

Spravato (esketamine) is a nasal spray that works on the brain’s glutamate system, specifically the NMDA receptor, rather than the serotonin system targeted by most antidepressants. This entirely different mechanism means it can succeed where multiple antidepressants have failed, and it often produces meaningful symptom relief within hours to days rather than the weeks required by traditional medications.

Spravato is FDA-approved for two indications: treatment-resistant depression (MDD in adults who have not adequately responded to two or more antidepressants) and major depressive disorder with active suicidal ideation. Sessions are conducted in-office at our Suwanee clinic. You self-administer the nasal spray under clinical supervision and are monitored for 2 hours after each dose before driving home.

Dr. Singareddy is a REMS-certified psychiatrist, the FDA’s mandatory certification required to prescribe and administer Spravato. He is one of a limited number of certified providers in the greater Johns Creek area. Most major insurance plans and Medicare cover Spravato for qualifying patients.

Why TMS and Spravato Work Well Together

For patients with complex, severe, or long-standing treatment-resistant depression, Dr. Singareddy may recommend a combined TMS + Spravato approach. The two treatments are highly complementary: Spravato rapidly promotes neuroplasticity through the glutamate system, which may enhance the brain’s responsiveness to the neural circuit stimulation delivered by TMS. Clinical experience suggests that some patients who haven’t achieved full remission with either treatment alone respond meaningfully to the combination.

 

Whether combination therapy is appropriate depends on your history, symptom severity, and prior treatment response and is determined through a thorough evaluation with Dr. Singareddy.

Conditions We Treat for Johns Creek Patients

We serve adults 18 and older with the full range of psychiatric conditions, with a particular specialty in cases where standard care has not achieved adequate results:

  • Major Depressive Disorder (MDD) — including treatment-resistant depression
  • Obsessive-Compulsive Disorder (OCD)
  • Anxiety disorders — Generalized Anxiety Disorder, Social Anxiety, Panic Disorder
  • PTSD and trauma-related disorders
  • Bipolar Disorder (depressive phases)
  • ADHD in adults
  • Schizophrenia and schizoaffective disorder
  • Major depression with active suicidal ideation (Spravato-eligible)
  • Sleep disorders — home sleep studies for patients whose mood disorders may involve undiagnosed sleep apnea

Why Johns Creek Patients Choose Empower Psychiatry & Sleep

  • Dr. Ravi Singareddy is board-certified psychiatrist with 20+ years of experience, Emory Healthcare Network affiliation, academic background at Penn State College of Medicine
  • BrainsWay Deep TMS: deeper, broader coverage than standard TMS; FDA-cleared for both depression AND OCD
  • REMS-certified Spravato program: one of the few certified providers accessible to Johns Creek residents
  • 3 board-certified PMHNPs (Psychiatric Mental Health Nurse Practitioners) for comprehensive care
  • GeneSight pharmacogenomic testing: DNA-guided medication selection to remove the guesswork from finding the right antidepressant
  • Home sleep studies: mood disorders are often complicated by undiagnosed sleep apnea; we evaluate both
  • Most major commercial insurance plans and Medicare accepted: our team handles prior authorization
  • Telehealth available for initial evaluations, follow-ups, and medication management
  • Saturday appointments: for working professionals who can’t take time off during the week
  • Now open in Cumming, GA: expanding access for North Fulton and Forsyth County patients.

Getting Started: Your Path from Johns Creek to Treatment

  • 1

    Initial contact – Call (770) 615-0226 or submit the TMS/Spravato interest form online. Telehealth consultations available.

  • 2

    Insurance verification – We confirm your coverage and handle all pre-authorization before treatment begins.

  • 3

    Comprehensive evaluation – Dr. Singareddy or one of our providers reviews your full psychiatric history, prior treatments, and current symptoms to determine whether TMS, Spravato, combination therapy, or another approach is most appropriate.

  • 4

    Personalized treatment plan – Your protocol is fully customized, TMS coil placement and frequency, Spravato dosing schedule, or a combination plan, based on your specific diagnosis and history.

  • 5

    Treatment course – TMS: 36 sessions over 6–7 weeks, 5 days/week, 20–40 min each. Spravato: twice-weekly for 4 weeks (induction), then weekly for 4 weeks (consolidation), then every 1–2 weeks (maintenance). Drive yourself home after every session.

  • 6

    Ongoing monitoring & follow-up – Response tracking throughout treatment, protocol adjustments as needed, and long-term maintenance planning to protect and sustain your improvement.

Conveniently Located for Johns Creek Patients

Our Suwanee clinic is located at 3390 Paddocks Pkwy, Suite 200, Suwanee, GA 30024 accessible from most Johns Creek neighborhoods in 10–15 minutes via Medlock Bridge Road or McGinnis Ferry Road to Buford Dam Road. Patients from the Windward, Technology Park, and Old Atlanta Road corridors find us especially convenient. Ample free parking is available on-site.

We also have a second location, now open, at 935 Buford Hwy, Suite 212, Cumming, GA 30041 expanding access for patients in North Fulton, Forsyth County, and East Cherokee County.

Insurance & Telehealth for Johns Creek Patients

We accept most major commercial insurance plans including Aetna, Blue Cross Blue Shield of Georgia, Cigna, UnitedHealthcare, Humana, and Medicare. TMS therapy for depression is covered by most major insurers when criteria for treatment-resistant depression are met. Spravato is covered by Medicare and most commercial plans for qualifying diagnoses. Our team handles prior authorization on your behalf, you will know your out-of-pocket cost before treatment begins.

Telehealth is available for new patient evaluations, medication management follow-ups, and consultation appointments, making it easy for busy Johns Creek professionals and families to fit psychiatric care into their schedules.

Not sure if TMS or Spravato is right for you?

We offer psychiatric consultation to review your history, answer your questions, and explain your options clearly. Most major insurance accepted. No referral required.

Frequently Asked Questions — TMS & Spravato Near Johns Creek, GA

TMS THERAPY QUESTIONS

Yes. Most major commercial insurance plans including Aetna, Blue Cross Blue Shield of Georgia, Cigna, UnitedHealthcare, and Humana cover TMS therapy for Major Depressive Disorder when at least one antidepressant medication has been tried without adequate results. Medicare also covers TMS for qualifying patients. Our team at Empower Psychiatry handles the full insurance verification and prior authorization process before treatment starts, so there are no surprises. We will give you a clear picture of your out-of-pocket costs before your first session.

Our Suwanee clinic at 3390 Paddocks Pkwy, Suite 200 is approximately 10–15 minutes from most Johns Creek neighborhoods. From the Medlock Bridge area, take Medlock Bridge Rd north to SR-20 west. From Technology Park or Old Atlanta Road, McGinnis Ferry Rd connects directly to Buford Dam Road. Our second location at 935 Buford Hwy, Suite 212, Cumming, GA is now open convenient for North Fulton and North Johns Creek patients.

A standard TMS treatment course consists of 36 sessions, delivered 5 days a week over approximately 6–7 weeks. Each session takes 20–40 minutes. During a session, you sit in a reclining chair and a helmet-like device is placed over your head. You will hear clicking sounds and feel a light tapping sensation on your scalp as the magnetic pulses are delivered. Most patients find this comfortable and easy to tolerate after the first few sessions. You remain fully awake throughout and can return to normal activities immediately afterward including driving.

Standard TMS devices use a figure-8 coil that can only stimulate the surface layer of the prefrontal cortex. BrainsWay Deep TMS uses a patented H-Coil helmet that stimulates both deeper and broader brain regions simultaneously, areas that are more directly implicated in mood regulation and that standard TMS cannot adequately reach. Multiple peer-reviewed studies and real-world clinical data show higher response and remission rates with Deep TMS compared to standard TMS coil systems. Additionally, BrainsWay is the only TMS system FDA-cleared for depression, anxious depression AND OCD, which matters greatly for patients dealing with these conditions. Empower Psychiatry is proud to offer this technology at our Suwanee clinic serving Johns Creek.

Yes. BrainsWay Deep TMS is FDA-cleared for Obsessive-Compulsive Disorder in addition to Major Depressive Disorder, making it one of very few treatments cleared for both. The OCD protocol uses a specific coil configuration that targets the anterior cingulate cortex and medial prefrontal cortex, brain regions that are demonstrably overactive in OCD. Each session is preceded by a brief symptom-provocation step that activates the OCD circuitry before stimulation, increasing treatment precision and effectiveness. Many Johns Creek patients with OCD who have had only partial results from SSRIs or from Exposure and Response Prevention (ERP) therapy have experienced significant improvement with Deep TMS.

TMS therapy has an excellent safety profile and is extremely well tolerated by the vast majority of patients. The most common side effect is mild scalp discomfort or a light headache at the treatment site during or shortly after the first few sessions, which typically resolves on its own within the first 1–2 weeks of treatment as your scalp adapts. Unlike antidepressant medications, TMS does not cause weight gain, sexual dysfunction, gastrointestinal problems, sedation, or cognitive impairment. There is no anesthesia, no recovery period, and no systemic effects. A very rare but serious risk is seizure (estimated at less than 1 in 10,000 sessions), which is discussed fully during your initial consultation. The overall long-term safety data for TMS therapy is substantially better than long-term antidepressant use for most patients.

Prior TMS treatment that didn’t produce expected results doesn’t mean TMS can’t work for you. The outcome of TMS therapy is highly dependent on the device used, the specific protocol, the number of sessions, and how precisely the treatment was targeted. At Empower Psychiatry, Dr. Singareddy will review your prior treatment in detail including the device, coil placement, pulse frequency, and your response over time and determine whether a different protocol, a different TMS target, a longer course, or a combined TMS + Spravato approach might achieve better results. We specialize in these complex cases and frequently see improvement in patients who had inadequate responses elsewhere.

SPRAVATO (ESKETAMINE) QUESTIONS

Spravato (esketamine) is an FDA-approved nasal spray for treatment-resistant depression and major depression with active suicidal ideation. It is a derivative of ketamine and works on the brain’s glutamate system, specifically the NMDA receptor, which is a completely different mechanism from traditional antidepressants that target serotonin, norepinephrine, or dopamine. This means Spravato can be effective for patients whose depression has not responded to multiple antidepressants. Equally important, it can produce meaningful symptom relief within hours to days of the first session, compared to the 4–6 weeks required by traditional medications. It is not a standalone cure but for many patients represents a genuine turning point after years of treatment frustration.

Yes. Spravato is covered by Medicare and most major commercial insurance plans, including Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Humana for patients who meet the clinical criteria. For treatment-resistant depression, the requirement is typically that two or more adequate antidepressant trials in the current depressive episode have not produced adequate results. For major depression with active suicidal ideation, the threshold is a current MDD diagnosis with documented suicidal ideation. Our team handles prior authorization and coordinates directly with your insurer before treatment begins. A patient assistance program is also available through the manufacturer for eligible patients who face coverage gaps.

Spravato sessions are conducted in our Suwanee clinic. When you arrive, you will self-administer the nasal spray device under the supervision of our clinical staff — the device is easy to use and our team will walk you through it. After each dose, you remain in our comfortable monitoring area for a mandatory 2-hour observation period during which we monitor your blood pressure, level of alertness, and any dissociative effects. Most patients experience mild dissociation (a slightly detached or dreamlike feeling) and sometimes mild nausea during the monitoring period, which resolves before you are cleared to leave. Because of the observation requirement, you will need someone to drive you home after each session and you cannot drive or operate heavy machinery until the following day. Bring a book, headphones, or simply rest during your monitoring time. Many patients find the sessions relaxing once they know what to expect.

The standard Spravato treatment schedule is structured in three phases: Induction (weeks 1–4): two sessions per week, for a total of 8 sessions. Consolidation (weeks 5–8): one session per week, for a total of 4 sessions. Maintenance (week 9 onward): one session every 1–2 weeks, based on your response and clinical judgment. Many patients begin noticing improvements in mood, energy, and motivation within the first 1–4 sessions of the induction phase. The maintenance schedule is adjusted over time based on how well your improvement is sustained. Dr. Singareddy will reassess your response at regular intervals and modify the plan accordingly.

Spravato is FDA-approved for two patient populations. First: adults with Treatment-Resistant Depression (TRD), defined as Major Depressive Disorder that has not responded adequately to at least two different antidepressant medications taken at adequate doses for adequate durations in the current episode. Second: adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior (MDSI), where rapid intervention is clinically warranted. To be evaluated at Empower Psychiatry, you should be 18 or older with a diagnosis of Major Depressive Disorder and a documented history of inadequate antidepressant response. Spravato is not appropriate for patients with certain medical or psychiatric contraindications — these are reviewed thoroughly during your evaluation.

Spravato and ketamine infusions are closely related but meaningfully different. Spravato uses esketamine, the S-enantiomer of ketamine, delivered as a regulated nasal spray, and is the only ketamine-derived treatment with full FDA approval for depression. Ketamine infusions use racemic ketamine (the complete molecule) delivered intravenously and are prescribed off-label for depression without FDA approval for this indication. The key advantages of Spravato over ketamine infusions include its FDA-approved status with a defined treatment protocol, coverage by Medicare and most commercial insurance (IV ketamine infusions are rarely covered), a safer nasal delivery route compared to IV administration, and robust post-market safety data from the REMS program. Empower Psychiatry offers Spravato as our esketamine treatment because of these regulatory and insurance advantages.

Yes. For patients with severe or complex treatment-resistant depression, Dr. Singareddy may recommend a combined TMS + Spravato protocol. The two treatments are highly complementary in mechanism: Spravato rapidly promotes neuroplasticity and new synaptic connections through glutamate signaling, while TMS delivers targeted magnetic stimulation to retrain the neural circuits that regulate mood. Research and clinical experience suggest that the brain’s enhanced plasticity during Spravato treatment may make it more responsive to TMS stimulation. Patients who have had inadequate results from either treatment alone are often evaluated for this combined approach. Whether combination therapy is right for you is determined individually during your consultation.

If Spravato does not produce adequate results after a full induction and consolidation course, the next steps depend on your overall clinical picture. Dr. Singareddy may evaluate whether the dosing schedule was optimal, whether TMS could be added or intensified, whether a different diagnosis (such as bipolar depression) might better explain your presentation, or whether other interventional approaches are appropriate. At Empower Psychiatry, we specialize in exactly these complex cases and do not give up after a single treatment approach. We also collaborate with your existing therapist or primary care provider to ensure your care is comprehensive and coordinated.

GENERAL QUESTIONS

No referral is required. You can contact us directly at (770) 615-0226 or through our online form to schedule a new patient evaluation. Many of our patients are referred by their primary care physicians or therapists and we actively collaborate with and provide updates to referring providers throughout Johns Creek and the broader North Atlanta area. If you have existing providers, we will coordinate with them as part of your care.

Yes. Telehealth appointments are available for initial consultations, medication management, follow-up visits, and psychiatric evaluations. This is especially convenient for Johns Creek patients with busy schedules, mobility limitations, or those who prefer to meet Dr. Singareddy virtually before committing to an in-person treatment program. TMS and Spravato sessions themselves require in-person visits at our Suwanee clinic, but all surrounding appointments and follow-ups can be conducted remotely.

Psychiatrist in Johns Creek, GA

Ravi Singareddy, MD: Affiliated with Emory Healthcare

Our Mission: Understanding and Compassion at the Forefront

Our mission is simple yet profound: to provide compassionate mental health care that seamlessly integrates the latest advances in medicine and psychiatry with your personal preferences and choices. We believe in treating the individual, not just the condition, ensuring a holistic path to wellness.

A Unique Approach to Mental Health Care

Dr. Singareddy’s affiliation with the Emory Healthcare Network, Georgia’s largest healthcare system, underscores our commitment to excellence. Specializing in the treatment of complex conditions such as treatment-resistant depression, OCD, and anxiety disorders, Dr. Singareddy employs evidence-based treatments tailored to the most recent medical insights. This approach not only fosters a compassionate care environment but also ensures that each treatment plan is as unique as the individuals we serve.

Ravi Singareddy.MD_Psychiatrist Suwanee.

Ready to explore TMS or Spravato in Johns Creek?

Call (770) 615-0226 or complete our interest form. Our team will verify your insurance and schedule your consultation — usually within 1–2 business days. Telehealth available. Saturday appointments offered.

START YOUR JOURNEY

CONTACT US!

Complete this form so we can assist with your mental health journey.

Name
Privacy Policy and Terms & Conditions

Visit https://atlantatms.clinic/privacy-policy/ to see our privacy policy and https://atlantatms.clinic/privacy-policy/ for our Terms of Service.